Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
The Intergroup | INTG | Jan 22, 2025 | 12.73 | -5.77 |
The J.M Smucker Company | SJM | Jan 22, 2025 | 102.15 | -1.25 |
The Joint | JYNT | Jan 22, 2025 | 11.11 | -2.54 |
The Marygold Companies | MGLD | Jan 22, 2025 | 1.64 | -1.80 |
The ODP | ODP | Jan 22, 2025 | 22.87 | -6.50 |
The OLB Group | OLB | Jan 22, 2025 | 1.82 | -1.09 |
The Oncology Institute | TOI | Jan 22, 2025 | 0.70 | +17.63 |
The ONE Group Hospitality | STKS | Jan 22, 2025 | 3.45 | +1.17 |
The Pennant Group | PNTG | Jan 22, 2025 | 27.47 | -1.58 |
The Real Brokerage | REAX | Jan 22, 2025 | 4.72 | +2.61 |
The Real Estate Select Sector SPDR Fund | XLRE | Jan 22, 2025 | 41.10 | -1.75 |
The RealReal | REAL | Jan 22, 2025 | 9.42 | -5.14 |
The RMR Group A | RMR | Jan 22, 2025 | 19.28 | -1.23 |
The Shyft Group | SHYF | Jan 22, 2025 | 12.43 | -1.27 |
The Trade Desk A | TTD | Jan 22, 2025 | 120.69 | -3.06 |
The9 ADR | NCTY | Jan 22, 2025 | 17.06 | +2.28 |
TherapeuticsMD | TXMD | Jan 22, 2025 | 1.04 | -0.95 |
Theratechnologies | THTX | Jan 22, 2025 | 1.72 | -3.11 |
Theravance Biopharma | TBPH | Jan 22, 2025 | 9.36 | +2.30 |
Theriva Biologics | TOVX | Jan 22, 2025 | 1.44 | -4.64 |
Thermo Fisher Scientific | TMO | Jan 22, 2025 | 574.59 | +0.27 |
Thermon Group | THR | Jan 22, 2025 | 29.89 | +0.07 |
Third Coast Bancshares | TCBX | Jan 22, 2025 | 33.36 | -0.74 |
Third Harmonic | THRD | Jan 22, 2025 | 5.84 | -2.67 |
Thomson Reuters | TRI | Jan 22, 2025 | 164.10 | +1.07 |
Thor Industries | THO | Jan 22, 2025 | 102.25 | -1.32 |
Thornburg Income Builder Opportunities Fund | TBLD | Jan 22, 2025 | 16.93 | -0.41 |
ThredUp A | TDUP | Jan 22, 2025 | 2.20 | -2.65 |
Thryv | THRY | Jan 22, 2025 | 16.19 | -0.19 |
Thumzup Media | TZUP | Jan 22, 2025 | 3.58 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.